They also don’t directly support behavior change, which Kathryn Ilonka Pollak, PhD, a professor in population health sciences ...

The author of a new guidebook on GLP-1s and other experts share their tips for how clinicians can optimize patient success ...

Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, ...

Boosting Bacteroides vulgatus in diabetic mice increased GLP-1 secretion, improving blood sugar control and reducing sugar ...

Researchers have discovered gut bacteria that may naturally suppress hunger, offering a potential alternative to drugs like ...

Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?

From indestructible tardigrades to body-merging comb jellies, animals can teach humans so much about medicine, robotics, aging and survival ...

A study shows GLP-1 weight-loss drugs reduce Alzheimer’s risk but increase arthritis, kidney, and pancreas issues.

Our research covers several areas including the study of islet endocrine cell physiology, identity and connectivity, biomarkers for type 2 diabetes, the role of nutrient regulated protein kinases, ...

If that person loses 20 kilograms (44 pounds) in one year while taking a GLP-1R agonist — which is not unreasonable while ...

molecular biology, and medicine, seeking novel and more effective drugs, which led to the approval of new hormones or their analogs for their therapeutic use in different countries. One example is the ...